Jubilant Ingrevia Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Jubilant Ingrevia has been growing earnings at an average annual rate of 8.8%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 6.5% per year. Jubilant Ingrevia's return on equity is 6.2%, and it has net margins of 4.3%.
Información clave
8.8%
Tasa de crecimiento de los beneficios
5.2%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 17.7% |
| Tasa de crecimiento de los ingresos | -6.5% |
| Rentabilidad financiera | 6.2% |
| Margen neto | 4.3% |
| Próxima actualización de resultados | 28 Jan 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Jubilant Ingrevia. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 41,104 | 1,755 | 9,096 | 0 |
| 30 Jun 24 | 40,851 | 1,740 | 3,920 | 0 |
| 31 Mar 24 | 41,358 | 1,829 | 3,923 | 0 |
| 31 Dec 23 | 42,063 | 2,059 | 3,921 | 0 |
| 30 Sep 23 | 43,982 | 2,589 | 3,733 | 0 |
| 30 Jun 23 | 46,819 | 2,857 | 3,548 | 0 |
| 31 Mar 23 | 47,727 | 3,075 | 3,515 | 0 |
| 31 Dec 22 | 49,235 | 3,238 | 3,421 | 0 |
| 30 Sep 22 | 50,516 | 3,613 | 3,480 | 0 |
| 30 Jun 22 | 49,706 | 3,878 | 3,284 | 0 |
| 31 Mar 22 | 49,494 | 4,767 | 3,298 | 0 |
| 31 Mar 21 | 6,841 | 544 | 497 | 0 |
Ingresos de calidad: 543271 has high quality earnings.
Margen de beneficios creciente: 543271's current net profit margins (4.3%) are lower than last year (5.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 543271's earnings have grown by 8.8% per year over the past 5 years.
Acelerando crecimiento: 543271's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Beneficios vs. Industria: 543271 had negative earnings growth (-32.2%) over the past year, making it difficult to compare to the Chemicals industry average (10.4%).
Rentabilidad financiera
Alta ROE: 543271's Return on Equity (6.2%) is considered low.